PMC:7558333 / 28816-29925 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T69","span":{"begin":165,"end":177},"obj":"Body_part"},{"id":"T70","span":{"begin":1055,"end":1060},"obj":"Body_part"}],"attributes":[{"id":"A69","pred":"fma_id","subj":"T69","obj":"http://purl.org/sig/ont/fma/fma14543"},{"id":"A70","pred":"fma_id","subj":"T70","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":"Table 7 Outcomes of patients with COVID-19-associated ARDS according to Aspergillus status.\nOutcomes All Patients (n = 45) No Aspergillosis (n = 30) Aspergillus Colonization (n = 8) Putative/Probable Invasive Aspergillosis (n = 7) p Value\nDuration of mechanical ventilation 17 (9–24) 17 (7–24) 18 (10–21) 18 (12–30) 0.66\nVentilator free days at day 28 11 (4–19) 11 (4–21) 10 (7–18) 10 (0–16) 0.64\nProne positioning ventilation 20 (44) 12 (46) 3 (37.5) 5 (71.4) 0.29\nSOFA score on day 7 7 (5–11) 6 (5–10) 8 (7–10) 11 (10–12) 0.01\nSOFA score on day 14 7 (2–10) 7 (2–9) 3 (1–7) 9 (2–12) 0.2\nICU length of stay 20 (12–27) 12 (11–23) 23 (16–51) 27 (20–36) 0.02\nDeath in ICU 6 (13.3) 4 (13.3) 0 2 * (28.6) 0.27\nData are presented as median (IQR: interquartiles), n (%). P values comparing Aspergillus colonization, invasive aspergillosis and no aspergillosis groups are tested by Kruskal Wallis (continuous variables) or Chi-square test (categorical variables). Abbreviations: ICU: Intensive Care Unit, SOFA: Sequential Organ Failure Assessment, * 1 putative and 1 probable."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T44","span":{"begin":1055,"end":1060},"obj":"Body_part"}],"attributes":[{"id":"A44","pred":"uberon_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"Table 7 Outcomes of patients with COVID-19-associated ARDS according to Aspergillus status.\nOutcomes All Patients (n = 45) No Aspergillosis (n = 30) Aspergillus Colonization (n = 8) Putative/Probable Invasive Aspergillosis (n = 7) p Value\nDuration of mechanical ventilation 17 (9–24) 17 (7–24) 18 (10–21) 18 (12–30) 0.66\nVentilator free days at day 28 11 (4–19) 11 (4–21) 10 (7–18) 10 (0–16) 0.64\nProne positioning ventilation 20 (44) 12 (46) 3 (37.5) 5 (71.4) 0.29\nSOFA score on day 7 7 (5–11) 6 (5–10) 8 (7–10) 11 (10–12) 0.01\nSOFA score on day 14 7 (2–10) 7 (2–9) 3 (1–7) 9 (2–12) 0.2\nICU length of stay 20 (12–27) 12 (11–23) 23 (16–51) 27 (20–36) 0.02\nDeath in ICU 6 (13.3) 4 (13.3) 0 2 * (28.6) 0.27\nData are presented as median (IQR: interquartiles), n (%). P values comparing Aspergillus colonization, invasive aspergillosis and no aspergillosis groups are tested by Kruskal Wallis (continuous variables) or Chi-square test (categorical variables). Abbreviations: ICU: Intensive Care Unit, SOFA: Sequential Organ Failure Assessment, * 1 putative and 1 probable."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T169","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"T170","span":{"begin":55,"end":59},"obj":"Disease"},{"id":"T171","span":{"begin":129,"end":142},"obj":"Disease"},{"id":"T172","span":{"begin":205,"end":227},"obj":"Disease"},{"id":"T173","span":{"begin":214,"end":227},"obj":"Disease"},{"id":"T174","span":{"begin":850,"end":872},"obj":"Disease"},{"id":"T175","span":{"begin":859,"end":872},"obj":"Disease"},{"id":"T176","span":{"begin":880,"end":893},"obj":"Disease"}],"attributes":[{"id":"A169","pred":"mondo_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A170","pred":"mondo_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A171","pred":"mondo_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A172","pred":"mondo_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A173","pred":"mondo_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A174","pred":"mondo_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A175","pred":"mondo_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A176","pred":"mondo_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"Table 7 Outcomes of patients with COVID-19-associated ARDS according to Aspergillus status.\nOutcomes All Patients (n = 45) No Aspergillosis (n = 30) Aspergillus Colonization (n = 8) Putative/Probable Invasive Aspergillosis (n = 7) p Value\nDuration of mechanical ventilation 17 (9–24) 17 (7–24) 18 (10–21) 18 (12–30) 0.66\nVentilator free days at day 28 11 (4–19) 11 (4–21) 10 (7–18) 10 (0–16) 0.64\nProne positioning ventilation 20 (44) 12 (46) 3 (37.5) 5 (71.4) 0.29\nSOFA score on day 7 7 (5–11) 6 (5–10) 8 (7–10) 11 (10–12) 0.01\nSOFA score on day 14 7 (2–10) 7 (2–9) 3 (1–7) 9 (2–12) 0.2\nICU length of stay 20 (12–27) 12 (11–23) 23 (16–51) 27 (20–36) 0.02\nDeath in ICU 6 (13.3) 4 (13.3) 0 2 * (28.6) 0.27\nData are presented as median (IQR: interquartiles), n (%). P values comparing Aspergillus colonization, invasive aspergillosis and no aspergillosis groups are tested by Kruskal Wallis (continuous variables) or Chi-square test (categorical variables). Abbreviations: ICU: Intensive Care Unit, SOFA: Sequential Organ Failure Assessment, * 1 putative and 1 probable."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T231","span":{"begin":121,"end":123},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T232","span":{"begin":165,"end":177},"obj":"http://purl.obolibrary.org/obo/UBERON_0001155"},{"id":"T233","span":{"begin":303,"end":305},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T234","span":{"begin":315,"end":317},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T235","span":{"begin":364,"end":366},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T236","span":{"begin":375,"end":377},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T237","span":{"begin":392,"end":394},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T238","span":{"begin":444,"end":451},"obj":"http://purl.obolibrary.org/obo/CLO_0001188"},{"id":"T239","span":{"begin":511,"end":515},"obj":"http://purl.obolibrary.org/obo/CLO_0001405"},{"id":"T240","span":{"begin":538,"end":540},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T241","span":{"begin":646,"end":648},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T242","span":{"begin":655,"end":657},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T243","span":{"begin":675,"end":677},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T244","span":{"begin":682,"end":684},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T245","span":{"begin":798,"end":806},"obj":"http://purl.obolibrary.org/obo/CLO_0008192"},{"id":"T246","span":{"begin":836,"end":848},"obj":"http://purl.obolibrary.org/obo/UBERON_0001155"},{"id":"T247","span":{"begin":905,"end":911},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T248","span":{"begin":967,"end":971},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T249","span":{"begin":1055,"end":1060},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"Table 7 Outcomes of patients with COVID-19-associated ARDS according to Aspergillus status.\nOutcomes All Patients (n = 45) No Aspergillosis (n = 30) Aspergillus Colonization (n = 8) Putative/Probable Invasive Aspergillosis (n = 7) p Value\nDuration of mechanical ventilation 17 (9–24) 17 (7–24) 18 (10–21) 18 (12–30) 0.66\nVentilator free days at day 28 11 (4–19) 11 (4–21) 10 (7–18) 10 (0–16) 0.64\nProne positioning ventilation 20 (44) 12 (46) 3 (37.5) 5 (71.4) 0.29\nSOFA score on day 7 7 (5–11) 6 (5–10) 8 (7–10) 11 (10–12) 0.01\nSOFA score on day 14 7 (2–10) 7 (2–9) 3 (1–7) 9 (2–12) 0.2\nICU length of stay 20 (12–27) 12 (11–23) 23 (16–51) 27 (20–36) 0.02\nDeath in ICU 6 (13.3) 4 (13.3) 0 2 * (28.6) 0.27\nData are presented as median (IQR: interquartiles), n (%). P values comparing Aspergillus colonization, invasive aspergillosis and no aspergillosis groups are tested by Kruskal Wallis (continuous variables) or Chi-square test (categorical variables). Abbreviations: ICU: Intensive Care Unit, SOFA: Sequential Organ Failure Assessment, * 1 putative and 1 probable."}

{"project":"LitCovid-sentences","denotations":[{"id":"T258","span":{"begin":0,"end":92},"obj":"Sentence"},{"id":"T259","span":{"begin":93,"end":244},"obj":"Sentence"},{"id":"T260","span":{"begin":245,"end":331},"obj":"Sentence"},{"id":"T261","span":{"begin":332,"end":412},"obj":"Sentence"},{"id":"T262","span":{"begin":413,"end":486},"obj":"Sentence"},{"id":"T263","span":{"begin":487,"end":554},"obj":"Sentence"},{"id":"T264","span":{"begin":555,"end":618},"obj":"Sentence"},{"id":"T265","span":{"begin":619,"end":691},"obj":"Sentence"},{"id":"T266","span":{"begin":692,"end":745},"obj":"Sentence"},{"id":"T267","span":{"begin":746,"end":804},"obj":"Sentence"},{"id":"T268","span":{"begin":805,"end":996},"obj":"Sentence"},{"id":"T269","span":{"begin":997,"end":1016},"obj":"Sentence"},{"id":"T270","span":{"begin":1017,"end":1043},"obj":"Sentence"},{"id":"T271","span":{"begin":1044,"end":1109},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 7 Outcomes of patients with COVID-19-associated ARDS according to Aspergillus status.\nOutcomes All Patients (n = 45) No Aspergillosis (n = 30) Aspergillus Colonization (n = 8) Putative/Probable Invasive Aspergillosis (n = 7) p Value\nDuration of mechanical ventilation 17 (9–24) 17 (7–24) 18 (10–21) 18 (12–30) 0.66\nVentilator free days at day 28 11 (4–19) 11 (4–21) 10 (7–18) 10 (0–16) 0.64\nProne positioning ventilation 20 (44) 12 (46) 3 (37.5) 5 (71.4) 0.29\nSOFA score on day 7 7 (5–11) 6 (5–10) 8 (7–10) 11 (10–12) 0.01\nSOFA score on day 14 7 (2–10) 7 (2–9) 3 (1–7) 9 (2–12) 0.2\nICU length of stay 20 (12–27) 12 (11–23) 23 (16–51) 27 (20–36) 0.02\nDeath in ICU 6 (13.3) 4 (13.3) 0 2 * (28.6) 0.27\nData are presented as median (IQR: interquartiles), n (%). P values comparing Aspergillus colonization, invasive aspergillosis and no aspergillosis groups are tested by Kruskal Wallis (continuous variables) or Chi-square test (categorical variables). Abbreviations: ICU: Intensive Care Unit, SOFA: Sequential Organ Failure Assessment, * 1 putative and 1 probable."}

{"project":"LitCovid-PubTator","denotations":[{"id":"674","span":{"begin":107,"end":115},"obj":"Species"},{"id":"675","span":{"begin":153,"end":164},"obj":"Species"},{"id":"676","span":{"begin":205,"end":227},"obj":"Disease"},{"id":"677","span":{"begin":692,"end":697},"obj":"Disease"},{"id":"682","span":{"begin":21,"end":29},"obj":"Species"},{"id":"683","span":{"begin":73,"end":84},"obj":"Species"},{"id":"684","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"685","span":{"begin":55,"end":59},"obj":"Disease"},{"id":"689","span":{"begin":824,"end":835},"obj":"Species"},{"id":"690","span":{"begin":850,"end":872},"obj":"Disease"},{"id":"691","span":{"begin":880,"end":893},"obj":"Disease"}],"attributes":[{"id":"A674","pred":"tao:has_database_id","subj":"674","obj":"Tax:9606"},{"id":"A675","pred":"tao:has_database_id","subj":"675","obj":"Tax:746128"},{"id":"A676","pred":"tao:has_database_id","subj":"676","obj":"MESH:D055744"},{"id":"A677","pred":"tao:has_database_id","subj":"677","obj":"MESH:D003643"},{"id":"A682","pred":"tao:has_database_id","subj":"682","obj":"Tax:9606"},{"id":"A683","pred":"tao:has_database_id","subj":"683","obj":"Tax:746128"},{"id":"A684","pred":"tao:has_database_id","subj":"684","obj":"MESH:C000657245"},{"id":"A685","pred":"tao:has_database_id","subj":"685","obj":"MESH:D012128"},{"id":"A689","pred":"tao:has_database_id","subj":"689","obj":"Tax:746128"},{"id":"A690","pred":"tao:has_database_id","subj":"690","obj":"MESH:D055744"},{"id":"A691","pred":"tao:has_database_id","subj":"691","obj":"MESH:D001228"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 7 Outcomes of patients with COVID-19-associated ARDS according to Aspergillus status.\nOutcomes All Patients (n = 45) No Aspergillosis (n = 30) Aspergillus Colonization (n = 8) Putative/Probable Invasive Aspergillosis (n = 7) p Value\nDuration of mechanical ventilation 17 (9–24) 17 (7–24) 18 (10–21) 18 (12–30) 0.66\nVentilator free days at day 28 11 (4–19) 11 (4–21) 10 (7–18) 10 (0–16) 0.64\nProne positioning ventilation 20 (44) 12 (46) 3 (37.5) 5 (71.4) 0.29\nSOFA score on day 7 7 (5–11) 6 (5–10) 8 (7–10) 11 (10–12) 0.01\nSOFA score on day 14 7 (2–10) 7 (2–9) 3 (1–7) 9 (2–12) 0.2\nICU length of stay 20 (12–27) 12 (11–23) 23 (16–51) 27 (20–36) 0.02\nDeath in ICU 6 (13.3) 4 (13.3) 0 2 * (28.6) 0.27\nData are presented as median (IQR: interquartiles), n (%). P values comparing Aspergillus colonization, invasive aspergillosis and no aspergillosis groups are tested by Kruskal Wallis (continuous variables) or Chi-square test (categorical variables). Abbreviations: ICU: Intensive Care Unit, SOFA: Sequential Organ Failure Assessment, * 1 putative and 1 probable."}